These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30367145)

  • 101. Antiangiogenic molecules from marine actinomycetes and the importance of using zebrafish model in cancer research.
    Nathan J; Kannan RR
    Heliyon; 2020 Dec; 6(12):e05662. PubMed ID: 33319107
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Induction of mitochondria-mediated apoptosis and suppression of tumor growth in zebrafish xenograft model by cyclic dipeptides identified from Exiguobacterium acetylicum.
    Jinendiran S; Teng W; Dahms HU; Liu W; Ponnusamy VK; Chiu CC; Kumar BSD; Sivakumar N
    Sci Rep; 2020 Aug; 10(1):13721. PubMed ID: 32792514
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Zebrafish patient avatars in cancer biology and precision cancer therapy.
    Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
    Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Zebrafish Models of Cancer-New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate.
    Hason M; Bartůněk P
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31731811
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparison of Endostar continuous versus intermittent intravenous infusion in combination with first-line chemotherapy in patients with advanced non-small cell lung cancer.
    Cheng Y; Nie L; Liu Y; Jin Z; Wang X; Hu Z
    Thorac Cancer; 2019 Jul; 10(7):1576-1580. PubMed ID: 31161695
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience.
    Greillier L; Tomasini P; Barlesi F
    Ther Adv Respir Dis; 2016 Oct; 10(5):485-91. PubMed ID: 27340254
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Current progression of bevacizumab in advanced non-small cell lung cancer].
    Chu TQ; Chen JH; Han BH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):793-800. PubMed ID: 30392346
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Anti-Angiogenics: Their Value in Lung Cancer Therapy.
    Janning M; Loges S
    Oncol Res Treat; 2018; 41(4):172-180. PubMed ID: 29631257
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model.
    Jin Y; Wei L; Jiang Q; Song X; Teng C; Fan C; Lv Y; Liu Y; Shen W; Li L; Huang D; Xin T
    Sci Rep; 2018 Oct; 8(1):15837. PubMed ID: 30367145
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer-bearing mice and patients.
    Liu M; Li H; Wang X; Jing L; Jiang P; Li Y
    Cancer Med; 2020 Apr; 9(8):2660-2673. PubMed ID: 32073228
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Efficacy and safety of rh-endostatin (Endostar) combined with pemetrexed/cisplatin followed by rh-endostatin plus pemetrexed maintenance in non-small cell lung cancer: A retrospective comparison with standard chemotherapy.
    Zhou S; Zuo L; He X; Pi J; Jin J; Shi Y
    Thorac Cancer; 2018 Nov; 9(11):1354-1360. PubMed ID: 30152052
    [TBL] [Abstract][Full Text] [Related]  

  • 112. The effect of apatinib combined with chemotherapy or targeted therapy on non-small cell lung cancer in vitro and vivo.
    Liu M; Wang X; Li H; Xu L; Jing L; Jiang P; Liu B; Li Y
    Thorac Cancer; 2019 Oct; 10(10):1868-1878. PubMed ID: 31486270
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance.
    Li F; Zhu T; Cao B; Wang J; Liang L
    Eur J Cancer; 2017 Oct; 84():184-192. PubMed ID: 28822888
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Recombinant human endostatin, Endostar, enhances the effects of chemo-radiotherapy in a mouse cervical cancer xenograft model.
    Jia Y; Liu M; Cao L; Zhao X; Wu J; Lu F; Li Y; He Y; Ren S; Ju Y; Wang Y; Li Z
    Eur J Gynaecol Oncol; 2011; 32(3):316-24. PubMed ID: 21797125
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Cancer statistics, 2018.
    Siegel RL; Miller KD; Jemal A
    CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Dabrafenib plus trametinib in patients with previously untreated BRAF
    Planchard D; Smit EF; Groen HJM; Mazieres J; Besse B; Helland Å; Giannone V; D'Amelio AM; Zhang P; Mookerjee B; Johnson BE
    Lancet Oncol; 2017 Oct; 18(10):1307-1316. PubMed ID: 28919011
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.